Araceli's Endeavor imaging system integrates into Ginkgo's autonomous lab to boost drug discovery AI data.

Araceli Biosciences has integrated its Endeavor high-content imaging system into Ginkgo Bioworks' autonomous lab, Nebula, in Boston. This integration enables rapid cellular imaging with real-time analysis, generating large datasets critical for training AI models in drug discovery. The Endeavor system can image a 1536-well plate in under four minutes and works continuously alongside other automated experiments. This advancement enhances the scale and speed of biological data generation, supporting more efficient and autonomous drug research workflows.

Ginkgo Bioworks Holdings Inc (DNA) trades at USD 11.21 on Pluang, down 2.27% as of Oct 08, 2026 17:11 WIB, with a market cap of $772.39M. This comes as the company advances its autonomous lab capabilities through integration with Araceli Biosciences' imaging system, enhancing its drug discovery processes. Pluang order activity shows a balanced interest with 42% Sell and 58% Buy, reflecting active engagement from investors.